Analysis explores North American pharmaceutical water, wastewater treatment market

The Environmental & Building Technologies practice at Frost & Sullivan will hold its 2008 Quarterly Analyst Briefing Presentation on the North American pharmaceutical water and wastewater treatment market on Thursday, Feb. 7, 2008 at 10:00 a.m. PT. This briefing will benefit treatment equipment manufacturers, distributors, turnkey solution providers, operations and maintenance solution providers, along with pharmaceutical drug manufacturer end users who utilize related products and services...

PALO ALTO, CA, Jan. 31, 2008 -- The Environmental & Building Technologies practice at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the North American pharmaceutical water and wastewater treatment market to be held on Thursday, February 7, 2008 at 10:00 a.m. PT.

The ever-changing pharmaceutical drug manufacturing industry has positively influenced the dynamic water and wastewater marketplace in 2006. The North American pharmaceutical drug manufacturing industry is governed by a high degree of regulatory, permit and validation requirements. By providing less expensive, high quality, as well as reliable equipment and technical services, the water and wastewater treatment markets are able to address the many needs of the pharmaceutical drug manufacturing industry.

This briefing will benefit treatment equipment manufacturers, distributors, turnkey solution providers, operations and maintenance solution providers, along with pharmaceutical drug manufacturer end users who utilize related products and services offered. Discussion of the emerging trends and forecast projections of the North American pharmaceutical water and wastewater treatment industry is vital to those who seek an enhanced market share within the industry, or those who aspire to enter this particular marketplace.

Highlights of the briefing include an analysis of the North American total market, brief commentary on segment breakdown, overview of Tier I pharmaceutical drug manufacturing end users, and a summary of the various industry related regulations.

"The stringent regulatory, validation and permit requirements that the pharmaceutical drug manufacturing industry must adhere to, poses a significant set of challenges for both water treatment and wastewater treatment equipment providers," observes Frost & Sullivan's Research Analyst Eric Meliton. "The result has been a dynamic effort amongst Tier I and Tier II treatment providers to adapt to these requirements, while still maintaining a level of durability, design quality and price competitiveness in the marketplace."

To participate, please email Johanna Haynes - Corporate Communications at johanna.haynes@frost.com with the following information: your full name, title, company name, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you. You may also register to receive a recorded version of the briefing at anytime by submitting the aforementioned contact details.

Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth.

###

More in Home